Massive carbamazepine overdose: Clinical and pharmacologic observations in five episodes

Neurology

Volumn 38, Issue 5, 1988, Pages 755-759

  Weaver, D F ^a   Camfield, Peter ^a   Fraser, Albert ^a  

^a DALHOUSIE UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATED CARBON; CARBAMAZEPINE; DIAZEPAM; PHENYTOIN;

ADULT; ADVERSE DRUG REACTION; CASE REPORT; DRUG OVERDOSE; FEMALE; HUMAN; MALE; NEUROTOXICITY; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; SEIZURE;

ADOLESCENT; ADULT; AGGRESSION; ATAXIA; CARBAMAZEPINE; CASE REPORT; CHOREA; COMA; FEMALE; HALLUCINATIONS; HUMAN; SEIZURES; SLEEP STAGES; SUICIDE, ATTEMPTED; TIME FACTORS;

EID: 0023933183     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/wnl.38.5.755     Document Type: Article

References (53)

1. Killian JM, Fromm GH. Carbamazepine in treatment of neuralgia: use and side effects. Arch Neurol 1968;19:129–136.
2. Redpath TH, Gayford TJ. The side effects of carbamazepine therapy. Oral Surg 1968;26:299–303.
3. Gruska H, Bever KH, Kubucki S, Schneider H. Course, toxicology and therapy of a case of severe carbamazepine poisoning. Arch Toxicol 1971;27:193–203.
4. Masland RL. Carbamazepine: neurotoxicity. In: Woodbury DM, Penry JK, Pippenger CE, eds. Antiepileptic drugs, 2nd ed. New York: Raven Press, 1982:521–531.
5. Stenger EG, Roulet FC. On the toxicity of the antiepileptic agent Tegretol. MedExp (Basel) 1964;11:191–201.
6. Kutt H, Solomon G, Wasterlain C, Peterson H, Louis S, Carruthers R. Carbamazepine in difficult to control epileptic outpatients. Acta Neurol Scand [Suppl] 1975;60:27–32.
7. Troupin AS, Ojemann LM. Paradoxical intoxication: a complication of anticonvulsant administration. Epilepsia 1968;16:753–758.
8. Hager H. Akute Tegretob-Vergiftung bei Zweizahringun Kind. Paediatr Prox 1965;4:241–243.
9. Lang-Peterson J. Poisoning with carbamazepine. Ugeskr Laeger 1969;131:1131–1133.
10. Livingston S, Pauli LI, Berman W. Carbamazepine in epilepsy. Dis New Syst 1974;35:103–107.
11. Dalby MA. Behavioral effects of carbamazepine. Adv Neurol 1975;11:331–344.
12. Rett A. Tegretol therapy in epileptic children. In: Wink CAS, ed. Tegretol in epilepsy. Manchester, UK: Nichols & Co., 1973:12–15.
13. Ganglberger JA. Erfahrungen mit dem psychotropen Antikonvulsivum Tegretol in der Neurochirurgie. Wien Med Wochenschr 1968;118:956–962.
14. Franks RD, Richter AJ. Schizophrenic-like psychosis associated with anticonvulsant toxicity. Am J Psychiatry 1979;131:973–974.
15. Stores G. Behavioral effects of antiepileptic drugs. Dev Med Child Neurol 1975;17:647–658.
16. Jacome D. Carbamazepine induced dystonia. JAMA 1979;241:2263.
17. Bradbury AJ, Todd PJ, Bentick B. Dystonia associated with carbamazepine toxicity. Postgrad Med J 1982;58:525–526.
18. Crosley CJ, Swender PT. Dystonia associated with carbamazepine administration. Paediatrics 1979;63:612–615.
19. Wendland KI. Myoclonus following doses of carbamazepine. Newenartz 1968;39:231–233.
20. Bimpong-Bula K, Froescher W. Carbamazepine induced choreoathetoid dyskinesias. J Neurol Neurosurg Psychiatry 1982;45:560–561.
21. Mullally WJ. Carbamazepine-induced ophthalmoplegia. Arch Neurol 1982;39:64.
22. Warot P, Arnott G, Delahousse J. Ataxie aigue apres ingestion massive de Tegretol. Lille Med 1967;12:601–604.
23. Henry EV. Oculogyric crisis and carbamazepine. Arch Neurol 1980;37:326.
24. DeZeeuw RA, Westenberg GM, Van der Kleijn E, Gimbrere JSF. An unusual case of carbamazepine poisoning with a near fatal relapse after two days. Clin Toxicol 1979;14:263–269.
25. Sullivan JB, Rumack BH, Peterson RG. Acute carbamazepine toxicity resulting from overdose. Neurology 1981;31:621–624.
26. May DC. Acute carbamazepine intoxication. South Med J 1984;77:24–26.
27. Denning DW, Matheson L, Bryson SM, Streete J, Berry DJ, Henry JA. Death due to carbamazepine self-poisoning: remedies reviewed. Hum Toxicol 1985;4:255–260.
28. Coutselinis A, Poulus L. An unusual case of carbamazepine poisoning. Clin Toxicol 1980;16:385–387.
29. Neuvonen PJ, Elonen E. Effect of activated charcoal on absorption and elimination of phenobarbitone and carbamazepine in man. Eur J Clin Pharmacol 1980;17:51–57.
30. Levy RH, Pitlick WHJ, Troupin AS, Green JR, Neal JM. Pharmacokinetics of carbamazepine in normal man. Clin Pharmacol Ther 1975;17:657–658.
31. Chan K, Agoanno JJ, Jansen R, Dietzler DN. Charcoal hemoperfusion for the treatment of carbamazepine poisoning. Clin Chem 1981;27:1300–1302.
32. Gary NE, Byra WM, Eisinger RP. Carbamazepine poisoning: treatment by haemoperfusion. Nephron 1981;27:203.
33. De Groot G, van Heijst AN, Maes RA. Charcoal haemoperfusion in the treatment of acute carbamazepine poisoning. J Toxicol Clin Toxicol 1984;22:349–362.
34. Nilsson C, Sterner G, Idvall J. Charcoal hemoperfusion for treatment of serious carbamazepine poisoning. Acta Med Scand [Suppl] 1984;216:137–140.
35. Salcman M, Pippenger CE. Acute carbamazepine encephalopathy. JAMA 1975;231:915.
36. Smoot CA, Wad DL. Carbamazepine toxicity. J Am Osteopath ASSOC 1977;76:758–760.
37. Taghevy A, Naumann L. Tegretol intoxication. Electroencephalogr Clin Neurophysiol 1971;30:264.
38. Rockoff S, Baselt RC. Severe carbamazepine poisoning. Clin Toxicol 1981;18:935–939.
39. Beerman B, Edhag O, Vallin H. Advanced heart block aggravated by carbamazepine. Br Heart J 1975;37:668–671.
40. Steiner C, Wit A, Wiess M. The antiarrhythmic actions of carbamazepine. J Pharmacol Exp Ther 1970;173:323–325.
41. Byrne E, Wong CH, Chambers DG, Rice JP. Carbamazepine therapy complicated by nodal bradycardia. Aust NZ J Med 1979;9:295–296.
42. Leslie PJ, Heyworth R, Prescott LF. Cardiac complications of carbamazepine intoxication: treatment by haemoperfusion. Br Med J 1983;286:1018.
43. Hoopen G, Nesthus I, Laerum OD. Fatal carbamazepine associated hepatitis. Acta Med Scand 1981;210:333–335.
44. Luke DR, Rocci ML, Schaible DH, Ferguson RK. Toxicokinetics of carbamazepine and its 10,11-epoxide. Vet Hum Toxicol 1985;28:315.
45. Luke DR, Rocci ML, Schaible DH, Ferguson RK. Acute hepatotoxicity after high doses of carbamazepine. Pharmacotherapy 1986;6:108–111.
46. Flegel KM, Cole CH. Inappropriate antidiuresis during carbamazepine treatment. Ann Intern Med 1977;87:722–723.
47. Henry DA, Lawson DH, Reavy P, Renfrew S. Hyponatremia during carbamazepine treatment. Br Med J 1977;1:83–84.
48. O’Neal W, Whitten KM, Baumann RJ, Blouin RA, Piecoro JJ. Lack of serious toxicity following carbamazepine overdose. Clin Pharm 1984;3:545–547.
49. Frigerio A, Morselli PL. Carbamazepine: biotransformation. Adv Neurol 1975;11:295–308.
50. Cotter LM, Eadie MS, Hooper WD. Pharmacokinetics of carbamazepine. Eur J Clin Pharmacol 1977;12:451–456.
51. Rawlins MD, Collste P, Bertilsson L. Elimination kinetics of carbamazepine in man. Eur J Clin Pharmacol 1975;8:91–96.
52. Patsalos PN, Stephenson TJ, Krishna S, Elyas AA, Lascelles PT, Wiles CM. Side-effects induced by carbamazepine-10,11-epoxide. Letter. Lancet 1985;2:496.
53. Goulden KJ, Camfield P, Dooley JM, et al. Severe carbamazepine intoxication after coadministration of erythromycin. J Pediatr 1986;109:135–138.